Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • GBardai
    Junior Member
    • Sep 2019
    • 2

    #1

    Deletions detected using Ion PGM not appearing when using Illumina

    Hello

    I was wondering if anyone has encountered the issue described below or maybe able to offer some guidance:

    Using the Ion PGM, Ampliseq Custom panel, we detected a heterozygous 12 bp deletion . In IgV, 150 reads have the deletion and 150 do not. This deletion was confirmed using Sanger sequencing.

    When using this same sample on the NextSeq550 (Sample and library prep was tansposon based NexteraFlex for Enrichment and target enrichment was IdT xGEN research panel probe set) this deletion is seen only 2 times in 80 reads.

    We attempted an alternative target enrichment set, TWIST Human Exome panel with RefSeq spike in, with the same sample and library prep system and once again came up with the same results. To rule out the sample and library prep, we are thinking to attempt this with a different enzyme fragmentation kit.

    From a bioinformatics perspective, Is there a possibility that the reads having the deletions are being filtered out when the fastq files are used to generate bam?

    Thanks
    Ghalib
  • colindaven
    Senior Member
    • Oct 2008
    • 417

    #2
    You don't mention any bioinformatics processes used, so it is impossible to answer your question.

    What you mean is during the read mapping pipeline (FASTQ-> BAM).

    We use NextSeq frequently and I would expect an indel of this size to be reliably detected using either single or paired end reads (PE always better).

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    17 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    26 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-13-2026, 09:56 AM
    0 responses
    22 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-09-2026, 11:14 AM
    0 responses
    28 views
    0 reactions
    Last Post SEQadmin2  
    Working...